Brokers Offer Predictions for VRTX FY2025 Earnings
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued to investors on Wednesday, February 19th. Cantor Fitzgerald analyst O. Brayer expects that the pharmaceutical company will post earnings per share of $16.12 for the year. Cantor Fitzgerald currently has […]
